A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

NCT00829166 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

991

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab emtansine
DRUG: Lapatinib
DRUG: Capecitabine

Sponsor

Hoffmann-La Roche